Patent Assignment
Reel/Frame 015788/0246
Assignment of Assignor's Interest
Recorded: 2005-03-17
Pages: 6
Assignor
PPL (HOLDINGS) LIMITED
Executed: 2005-01-07
Assignee
PHARMING INTELLECTUAL PROPERTY BV
P.O. BOX 451, AL LEIDEN, 2300, NETHERLANDS
Covered Properties
(9)
Peptide Production
Patent:
5,366,894 →
Application:
07/796,439 →
Peptide Production
Patent:
5,322,775 →
Application:
07/796,917 →
Peptide Production
Patent:
5,476,995 →
Application:
07/931,864 →
Genetic Construct of Which Protein Coding Dna Comprises Introns and Is Designed for Protein Production in Transgenic Animals
Patent:
5,861,299 →
Application:
08/343,884 →
Genetic Construct of Which Protein Coding Dna Comprises Introns and Is Designed for Protein Production in Transgenic Animals
Patent:
5,650,503 →
Application:
08/359,854 →
Peptide Production
Application:
08/449,797 →
Production of Heterologous Protein in Milk of Transgenic Non-Human Mammals Comprising a Construct with an Intron
Patent:
6,548,735 →
Application:
08/781,518 →
Purification of Alpha-1 Proteinase Inhibitor
Patent:
6,194,553 →
Application:
09/036,796 →
Purification of Alpha-1 Proteinase Inhibitor
Patent:
6,525,176 →
Application:
09/612,592 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Grant of a Security Interest in Grantor's (Debtor's) Ownership Rights to Grantee (Secured Party)
Feb 27, 2006
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017215/0991 →
Release of Security Interest
Mar 2, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 024016/0508 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →